Improving Care After Chemotherapy

Completed · Not applicable

Conditions studied: Non-small Cell Lung Cancer, Colorectal Cancer, Breast Cancer

In brief

The main purpose of this study is to examine changes in patient-reported symptoms during the first two cycles of neoadjuvant or adjuvant chemotherapy for non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and breast cancer, among patients who receive standard care plus a proactive nursing intervention relative to patients who receive standard care alone. Interventions to improve symptom management and prevent urgent care needs in both the clinic and hospital for patients receiving chemotherapy with curative intent are needed to enhance the quality of cancer care.

Key facts

Study ID

NCT01944137

Run by

Massachusetts General Hospital

People needed

120

Starts

2013-09-01

Expected to finish

2017-02-02

Last updated by the study team

2020-09-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (age 18 or older)
• Newly diagnosed stage I-III colorectal cancer, non-small-cell lung cancer, or breast cancer
• Scheduled to receive neoadjuvant chemotherapy (i.e. pre-surgical cancer-directed therapy with curative intent) or adjuvant chemotherapy (i.e. post-surgical cancer-directed therapy with curative intent)
• Able to respond to questions in English

You may not qualify if…

• Already received 1 or more cycles of chemotherapy for the current regimen
• Unwilling or unable to participate in the study

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.